Aug 27, 2025
The global grow light market size was valued at USD 4.8 Billion in 2024. Looking forward, IMARC Group estimates the market to reach USD 9.4 Billion by 2033, exhibiting a CAGR of 7.9% during 2025-2033.
Jun 25, 2025
The B-cell lymphoma market reached a value of USD 5.0 Billion across the top 7 markets (US, EU4, UK, and Japan) in 2024. Looking forward, IMARC Group expects the top 7 major markets to reach USD 9.2 Billion by 2035.
Jun 20, 2025
The 7 major chronic sialorrhea markets reached a value of US$ 1.4 Billion in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 2.2 Billion by 2034, exhibiting a growth rate (CAGR) of 4.15% during 2024-2034.
Jun 13, 2025
The acute lymphoblastic leukemia market reached a value of USD 2,270.5 Million across the top 7 markets (US, EU4, UK, and Japan) in 2024.
Jun 12, 2025
The top 7 (US, EU4, UK, and Japan) advanced pancreatic cancer markets are expected to exhibit a CAGR of 5.56% during 2025-2035.
Jun 09, 2025
The 7 major gastroesophageal reflux disease markets reached a value of USD 5.1 Billion in 2024.
Jun 06, 2025
The down syndrome market reached a value of USD 1.3 Billion across the top 7 markets (US, EU4, UK, and Japan) in 2024.
Jun 05, 2025
The 7 major hypertrophic cardiomyopathy markets reached a value of US$ 312.5 Million in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 356.7 Million by 2034, exhibiting a growth rate (CAGR) of 1.21% during 2024-2034..
Jun 02, 2025
TThe 7 major valley fever markets reached a value of USD 717.46 Million in 2024. Looking forward, IMARC Group expects the 7MM to reach USD 1,046.45 Million by 2035.
May 30, 2025
The 7 major uveal melanoma markets reached a value of USD 1,000 Million in 2024.